Javascript must be enabled to continue!
Synergistic Inhibitory Effect of Angiotensin-Converting Enzyme Inhibitor and Heparin on Intimal Hyperplasia After Rat Aorta Injury
View through CrossRef
The respective efficacies of angiotensin-converting enzyme (ACE) inhibitor and standard heparin were investigated with respect to their inhibitory effects on intimal hyperplasia after balloon denudation of rat aorta. Local angiotensin II effects in the artery wall may participate in regulation of the vascular response to arterial injury, apparently independent of the plasma renin and angiotensin system. ACE inhibitors have been shown to block intimal hyperplasia after arterial injury in rats. Increasing evidence points toward an inhibitory effect of heparin on intimal hyperplasia independent of anticoagulation. Balloon catheter aortic denudation was performed in 25 rats pharmacologically treated from six days or one day before to fourteen days after surgery and split into four groups: group A (control group), normal feeding; group B (ramipril group), ramipril 10 mg/kg/day orally; group C (heparin group), heparin 1200 IU/kg/day subcutaneously; group D (combined group), both ramipril and heparin. Animals were killed and aortas were perfused and fixed at physiologic pressure fourteen days after denudation. Cross-sectional intima-to-media area ratios (I-M ratio) were calculated by an image analyzer system. (continued on next page) Morphometric analysis of cross sections showed marked intimal thickening in the control group with a mean I-M ratio of 95.1 ±2.76%. In contrast, the I-M ratios in the ramipril group were significantly reduced by 37.3 ±2.06% (P = 0.0001) and in the heparin group by 29.7 ± 1.58%. The I-M ratio of animals treated with both ramipril and heparin was 16.6 ±1.3% (P=0.0001) (Figs. 1-7). Blood pressure in the ramipril group decreased from 111.7 ±5.16 mmHg and 91.7 ±2.58 mmHg (P = 0.0001) and in the combined group from 111.7 ± 6.06 mmHg to 92.5 ± 5.24 mmHg and 85.0 ±3.16 mmHg (P=0.0001) after seven days and fourteen days, respectively, whereas heparin had no effect on blood pressure (114.2 ±8.61 mmHg to 111.7 ±6.06 mmHg and 111.7 ±4.08 mmHg) (Fig. 8). Both the ACE inhibitor ramipril and heparin significantly reduced intimal hyperplasia. More significant reduction of intimal hyperplasia was obtained when these two drugs were given together. These data have led the authors to conclude that ACE inhibitors and heparin together inhibit intimal thickening after injury, and an apparently synergistic effect of these two drugs may be obtained. These results may be useful for clinical application to prevent the proliferation that occur after endarterectomy or bypass surgery.
Title: Synergistic Inhibitory Effect of Angiotensin-Converting Enzyme Inhibitor and Heparin on Intimal Hyperplasia After Rat Aorta Injury
Description:
The respective efficacies of angiotensin-converting enzyme (ACE) inhibitor and standard heparin were investigated with respect to their inhibitory effects on intimal hyperplasia after balloon denudation of rat aorta.
Local angiotensin II effects in the artery wall may participate in regulation of the vascular response to arterial injury, apparently independent of the plasma renin and angiotensin system.
ACE inhibitors have been shown to block intimal hyperplasia after arterial injury in rats.
Increasing evidence points toward an inhibitory effect of heparin on intimal hyperplasia independent of anticoagulation.
Balloon catheter aortic denudation was performed in 25 rats pharmacologically treated from six days or one day before to fourteen days after surgery and split into four groups: group A (control group), normal feeding; group B (ramipril group), ramipril 10 mg/kg/day orally; group C (heparin group), heparin 1200 IU/kg/day subcutaneously; group D (combined group), both ramipril and heparin.
Animals were killed and aortas were perfused and fixed at physiologic pressure fourteen days after denudation.
Cross-sectional intima-to-media area ratios (I-M ratio) were calculated by an image analyzer system.
(continued on next page) Morphometric analysis of cross sections showed marked intimal thickening in the control group with a mean I-M ratio of 95.
1 ±2.
76%.
In contrast, the I-M ratios in the ramipril group were significantly reduced by 37.
3 ±2.
06% (P = 0.
0001) and in the heparin group by 29.
7 ± 1.
58%.
The I-M ratio of animals treated with both ramipril and heparin was 16.
6 ±1.
3% (P=0.
0001) (Figs.
1-7).
Blood pressure in the ramipril group decreased from 111.
7 ±5.
16 mmHg and 91.
7 ±2.
58 mmHg (P = 0.
0001) and in the combined group from 111.
7 ± 6.
06 mmHg to 92.
5 ± 5.
24 mmHg and 85.
0 ±3.
16 mmHg (P=0.
0001) after seven days and fourteen days, respectively, whereas heparin had no effect on blood pressure (114.
2 ±8.
61 mmHg to 111.
7 ±6.
06 mmHg and 111.
7 ±4.
08 mmHg) (Fig.
8).
Both the ACE inhibitor ramipril and heparin significantly reduced intimal hyperplasia.
More significant reduction of intimal hyperplasia was obtained when these two drugs were given together.
These data have led the authors to conclude that ACE inhibitors and heparin together inhibit intimal thickening after injury, and an apparently synergistic effect of these two drugs may be obtained.
These results may be useful for clinical application to prevent the proliferation that occur after endarterectomy or bypass surgery.
Related Results
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...
Development of angiotensin (1‐7) as an agent to accelerate dermal repair
Development of angiotensin (1‐7) as an agent to accelerate dermal repair
Angiotensin II has been shown to be a potent agent in the acceleration of wound repair. Angiotensin (1‐7), a fragment of angiotensin II that is not hypertensive, was found to be co...
HEPARIN STIMULATES FIBROBLAST GROWTH INDUCED BY PDGF
HEPARIN STIMULATES FIBROBLAST GROWTH INDUCED BY PDGF
Heparin binds to smooth muscle cells and endothelial cells. It inhibits the proliferation of the smooth muscle cells and modulates the growth of endothelial cells. Fibroblasts whic...
Case Report: Maggots' Infestation As a Predisposing Condition for Heparin-Induced Thrombocytopenia, a Newest Entity
Case Report: Maggots' Infestation As a Predisposing Condition for Heparin-Induced Thrombocytopenia, a Newest Entity
Abstract
Introduction
Thromobocytopenia is a well-recognized complication of heparin with risk of venous or arterial thrombosis. Heparin induced throm...
Abstract 125: Modified Angiotensin II Has Lower Vasoconstrictive Effect Than Angiotensin II
Abstract 125: Modified Angiotensin II Has Lower Vasoconstrictive Effect Than Angiotensin II
Introduction:
The renin-angiotensin-aldosterone system (RAAS) is involved in the regulation of the blood pressure, water- and electrolyte balance. Pathophysiologically,...
Development of a Model for Plaque Induction in Rat Carotid Arteries
Development of a Model for Plaque Induction in Rat Carotid Arteries
Abstract
Objective Plaque induction through intimal injury using a balloon catheter in small animals and by artificial ligation of the carotid artery in large animals hav...
The mechanism of oxidative stress in keloid fibroblasts and the experimental study of early application of angiotensin-converting enzyme inhibitor
The mechanism of oxidative stress in keloid fibroblasts and the experimental study of early application of angiotensin-converting enzyme inhibitor
Objective
To investigate the protective effects of an angiotensin-converting enzyme inhibitor after inducing oxidative stress on keloid fibroblasts.
Methods
Primary keloid fibrob...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
14th Annual Meeting, December 1980, Canberra1. Effect of dexamethasone on pineal β‐adrenoceptors. C. A. Maxwell, A. Foldes, N. T. Hinks and R. M. Hoskinson2. A clinicopathological ...

